文献速递胸部肿瘤

常规临床参数预测模型对接受减瘤手术的恶性胸膜间皮瘤患者生存分层

Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery.
PubMed 文献 · J Thorac Oncol · 2018-10-24

模型将患者分为4个风险组,各组生存差异显著(p<0.0001),36个月Harrell一致性统计量为0.62(95%CI 0.57-0.66)。无体重减轻、血红蛋白>153 g/L且血清白蛋白>43 g/L者生存最长(中位82.5个月)。

要点

  • CART模型可基于常规临床变量对手术MPM患者进行生存分层,区分度尚可。
  • 体重减轻、贫血和低白蛋白提示手术需谨慎。
  • 无体重减轻且血红蛋白>153 g/L、白蛋白>43 g/L者中位生存达82.5个月。

核心结论

  • 基于常规临床变量的CART模型能将接受减瘤手术的MPM患者分为生存显著不同的风险组,区分度尚可。
  • 体重减轻、贫血和低白蛋白血症在考虑手术治疗时应引起警惕。

研究设计与样本

  • 应用既往描述的CART模型,根据临床变量组合将患者分为风险组1至4,比较生存特征。

主要发现

  • 总体中位生存期为34.6个月(四分位距17.5-56.1),中位年龄63.0岁(四分位距57.0-67.8),男性占83.0%(n=240)。
  • 两个队列之间无临床意义的差异。
  • 四个风险组间生存差异显著(p<0.0001),模型在36个月时的Harrell一致性统计量为0.62(95%CI 0.57-0.66)。
  • 生存最长组(中位82.5个月)的特征为:转诊至手术中心时无体重减轻、血红蛋白>153 g/L且血清白蛋白>43 g/L。

临床怎么用

  • 在考虑对MPM患者进行减瘤手术时,可应用该CART模型基于常规临床变量进行风险分层。
  • 存在体重减轻、贫血或低白蛋白的患者手术需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Malignant pleural mesothelioma (MPM) is an uncommon cancer with a poor prognosis and heterogeneous survival. Surgery for MPM is offered in some specialist centers to highly selected patients. A previously described classification and regression tree (CART) model stratified survival in unselected MPM patients using routinely collected clinical data. This study aimed to examine the performance of this CART model on a highly selected surgical population. METHODS: Data were collected from subjects undergoing cytoreductive surgery for MPM from specialist centers in Hyõgo, Japan, and Sydney, Australia, between 1991 and 2016. The CART model was applied using the combination of clinical variables to stratify subjects into risk groups (1 through 4); survival characteristics were then compared. RESULTS: Two hundred eighty-nine cases were included (205 from Australia, 84 from Japan). Overall median survival was 34.6 (interquartile range: 17.5-56.1) months; median age was 63.0 (interquartile range: 57.0-67.8) years, and 83.0% (n = 240) were male. There were no clinically meaningful differences between the two cohorts. Survival across the four risk groups was significantly different (p < 0.0001); the model stratified survival well with a Harrell's concordance statistic of 0.62 (95% confidence interval: 0.57-0.66) at 36 months. The group with the longest survival (median, 82.5 months) had: no weight loss, hemoglobin > 153 g/L and serum albumin > 43 g/L at time of referral to the surgical center. CONCLUSIONS: Using routinely available clinical variables, the CART model was able to stratify surgical patients into risk groups with statistically different survival characteristics with fair to good performance. Presence of weight loss, anemia, and low albumin should confer caution when considering surgical therapy for MPM.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Harris EJA, Kao S, McCaughan B, et al. Prediction modelling using routine clinical parameters to stratify survival in Malignant Pleural Mesothelioma patients undergoing cytoreductive surgery. J Thorac Oncol. 2018. PMID: 30366103. doi:10.1016/j.jtho.2018.10.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。